In this study, treatment with the EPS significantly down-regulated (p < 0.05) the levels of NF-κB p65, p-IKKβ, and p-IκBα, indicating that the EPS alleviated IBD by the mechanism of regulation on NF-κB signaling pathway. The gene discussed is NFKB1; the disease is inflammatory bowel disease.